Catalyst Pharmaceuticals, Inc. Public Market Comparables
Find the most relevant public market comparables for Catalyst Pharmaceuticals, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
A commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients with rare and difficult-to-treat diseases.
Business Model
Developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases.
Target Customers
Patients with rare, debilitating, chronic neuromuscular and neurological diseases.
Specific Focus
Rare disease therapeutics
Location
Coral Gables, Florida
CEO
Richard Daly
Industry
Life sciences
Sub Sector
Biotechnology: Pharmaceutical Preparations
3yr Revenue Growth
234%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Catalyst Pharmaceuticals, Inc. in the Health Care sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Catalyst Pharmaceuticals, Inc.? Our platform provides detailed analysis of Catalyst Pharmaceuticals, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Catalyst Pharmaceuticals, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Catalyst Pharmaceuticals, Inc. Compset
As a leading player in the Life sciences industry within the Health Care sector, Catalyst Pharmaceuticals, Inc. operates in the specialized Biotechnology: Pharmaceutical Preparations sub-sector. Understanding how Catalyst Pharmaceuticals, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology: Pharmaceutical Preparations space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Harmony Biosciences Holdings, Inc.
Pharmaceuticals • Life sciences
A commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company is dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs.
Arvinas Inc.
Pharmaceuticals & Biotech • Life sciences
Arvinas is a clinical-stage biopharmaceutical company focused on developing new therapeutics for cancers and other difficult-to-treat diseases. Their proprietary PROTAC® protein degraders harness the body's natural protein disposal system to degrade disease-causing proteins.
Aclaris Therapeutics Inc.
Biotechnology • Life sciences
Aclaris Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics (identifying and developing therapies for immuno-inflammatory diseases) and contract research (providing laboratory services). A majority of its revenue comes from the therapeutics segment.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Catalyst Pharmaceuticals, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free